How CBD and CBG Can Transform Lives: Real Stories of Seizure Relief

Table of Contents

• Understanding CBD and CBG
• Therapeutic Benefits
• Real-Life Impact
• Safety & Guidance
• The Future of Cannabinoid Research

Understanding CBD and CBG

CBD (cannabidiol) and CBG (cannabigerol) are non-psychoactive cannabinoids. They interact with the body’s endocannabinoid system. These cannabinoids help regulate mood, inflammation, and neurological function. While CBD is widely available and studied, CBG is rarer but shows growing promise for neuroprotective effects. Learn more in our article Understanding the Entourage Effect.

Property	CBD	CBG
Availability	High	Low
Effects	Calming, anti-anxiety	Focus-enhancing, neuroprotective
Receptor Binding	Indirect (CB1, CB2)	Direct (CB1, CB2)
Research	Extensive	Emerging

Therapeutic Benefits

CBD modulates GABA neurotransmitters and reduces neural inflammation—key actions for seizure control. CBG may regulate neurotransmitter release and protect against oxidative stress. Both cannabinoids are being studied for their anticonvulsant properties, especially in drug-resistant epilepsy.

Reducing Seizure Frequency

CBD has been shown to reduce seizures by enhancing inhibitory signaling and calming hyperactive neural pathways. CBG’s potential to reduce oxidative brain stress offers an additional neuroprotective mechanism. See our full article Effective Strategies for Pain Management with CBD.

Enhancing Seizure Management

• CBD helps reduce anxiety and improve sleep—common epilepsy comorbidities
• CBG may complement this with anti-inflammatory and mood-stabilizing effects

Medication Interactions

CBD can increase blood levels of certain antiepileptic drugs (AEDs). Regular monitoring and professional consultation are crucial. CBG’s interaction profile is less understood but may be milder.

Real-Life Impact

Many report reduced seizure activity, better sleep, and enhanced mental clarity after using CBD or CBG. Anecdotes from parents and adult patients highlight quality-of-life improvements.

Pediatric Success Stories

CBD has reduced seizure frequency in children with drug-resistant epilepsy. Improvements in cognitive function and emotional regulation have also been observed in some cases. See our in-depth coverage in Discover How CBD Transforms Lives for Veterans.

CBD for Dogs

A study by the American Veterinary Medical Association found that 89% of epileptic dogs treated with CBD had fewer seizures. Dosing and safety should be discussed with a veterinarian.

Safety & Guidance

Common side effects of CBD include fatigue and appetite changes. CBG’s side effects are still under review. Interactions with other medications, especially those processed by the liver, should be monitored.

Delivery & Dosage

• Oils: Fast-acting and easy to adjust
• Capsules: Convenient but slower onset
• Start low, go slow: Gradually increase dosage to monitor results and tolerance

The Future of Cannabinoid Research

Ongoing studies explore personalized cannabinoid combinations, nano-delivery methods, and long-term effects on the brain. Combined therapies (CBD + AEDs) show early promise in reducing required dosages while maintaining seizure control. See updates in The Untold Story of U.S. Patent US20130059018.

Potential Research Directions

• Optimal CBD:CBG ratios
• Genetic predictors for cannabinoid response
• Extended safety profiling in pediatric and geriatric groups

References

American Veterinary Medical Association – CBD for Dogs

CBD and Dravet Syndrome – NEJM

CBD for Lennox-Gastaut – The Lancet